EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—September 7, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI)
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—June 30, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—June 16, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announces it has been awarded a grant from the European Innovation Council (EIC) to support the development of an innovative Brain-Spine Interface technology for restoring mobility and upper limb function.
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—June 13, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces the appointment of Kristina Dziekan to its Board of Directors.
